Teleflex Introduces the AsthmaMDTM Peak Flow Meter
April 20 2017 - 6:45AM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies for critical care and surgery, has announced
its launch of the AsthmaMDTM Peak Flow Meter designed to help
asthma patients to track and measure lung performance.
Asthma is a chronic disease characterized by recurrent attacks
of breathlessness and wheezing which can vary in severity and
frequency from person to person.1 According to the Centers for
Disease Control, 1 in 13 people have asthma2 and each year, asthma
causes 1.6 million emergency visits3 and 439,000 hospital
stays.4
The AsthmaMDTM Peak Flow Meter was developed for use with the
AsthmaMDTM smartphone app, which helps patients digitally log peak
flow meter readings, track symptoms, medications, and notes –
empowering patients to create a digital journal of their asthma
activity. Offered currently as a complimentary download by
AsthmaMD, Inc., * the smartphone companion app encourages patients
to share their activity with their physician care team via the
cloud-based MyAsthmaMDTM Physician Portal (also offered by
AsthmaMD, Inc.).
“Teleflex is committed to connecting clinicians and patients
with technology that improves patient outcomes,” said James
Ferguson, President Respiratory Division, Teleflex Incorporated.
“Asthma is the third-leading cause of hospitalization in children5
and Teleflex is proud to now offer the AsthmaMDTM Peak Flow Meter
to help these and other asthma patients.”
To learn more about the asthma management portfolio from
Teleflex, please visit Teleflex.com.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies
designed to improve the health and quality of people’s lives. We
apply purpose-driven innovation – a relentless pursuit of
identifying unmet clinical needs – to benefit patients and
healthcare providers. Our portfolio is diverse, with solutions in
the fields of vascular and interventional access, surgical,
anesthesia, cardiac care, urology, emergency medicine, and
respiratory care. Teleflex employees worldwide are united
in the understanding that what we do every day makes a difference.
For more information, please visit teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management’s current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
*DISCLAIMER: The AsthmaMDTM mobile app and MyAsthmaMDTM
Physician Portal are third-party products offered by AsthmaMD, Inc.
Teleflex has no control over such third-party products, nor does
Teleflex review, approve, monitor, endorse, or make any
representations or warranties with respect to such third-party
products.
References:
1.
Asthma. World Health Organization.
http://www.who.int/topics/asthma/en/. Accessed March 22, 2017
2.
Asthma. Centers for Disease Control.
https://www.cdc.gov/asthma/default.htm. Accessed March 22, 2017
3.
National Center for Health Statistics.
Centers for Disease Control.
https://www.cdc.gov/nchs/fastats/asthma.htm Accessed March 22,
2017
4.
Most Recent Asthma Data. Centers for
Disease Control. https://www.cdc.gov/asthma/most_recent_data.htm
Accessed March 22, 2017
5.
Asthma Facts. United States Environmental
Protection Agency.
https://www.epa.gov/sites/production/files/2016-05/documents/asthma_fact_sheet_english_05_2016.pdf
Accessed March 22, 2017
AsthmaMD and MyAsthmaMD is a trademark of Genia Medical,
Inc.
Teleflex, the Teleflex logo, and Hudson RCI are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates,
in the U.S. and/or other countries. © 2017 Teleflex Incorporated.
All rights reserved. MC-003204
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170420005040/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024